R1159Q (p.Arg1159Gln) variant of SMARCA2 (P51531)
R1159Q (p.Arg1159Gln) in SMARCA2 (P51531) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of SMARCA2-related BAFopathy; not provided; Nicolaides-Baraitser syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.92 / 1. The record also includes published literature and structural context.
R1159Q (p.Arg1159Gln) variant details
- p.Arg1159Gln
- rs281875187
- ClinGen CA211263
- NCI-TCGA Cosmic COSV6181
- Pathogenic/Likely pathogenic
- SMARCA2-related BAFopathy; not provided; Nicolaides-Baraitser syndrome
- Missense
- Variant Prioritization Score for Impact Estimate 0.922
- AlphaMissense 0.99
- MetaLR 0.99
- MetaSVM 0.95
- PolyPhen-2 1.00
- SIFT 0.00
- EVE 0.73
- ClinVar: Pathogenic/Likely pathogenic (SMARCA2-related BAFopathy; not provided; Nicolaides-Baraitser sy)
- EBI: Pathogenic (in NCBRS)
- UniProt: Pathogenic (in NCBRS)
- Structural context available
- Cited in: Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome. (PMID 22366787)
- Cited in: SMARCA2-Related Nicolaides-Baraitser Syndrome. (PMID 26468571)